News
A significant number of patients taking Bruton tyrosine kinase inhibitors (BTKis) for chronic lymphocytic leukemia (CLL) develop atrial fibrillation (AF).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback